Effect of ω-3 polyunsaturated fatty acid on toll-like receptors in patients with severe multiple trauma

Journal of Huazhong University of Science and Technology - Medical Science

Volumn 31, Issue 4, 2011, Pages 504-508

  Yi, Chengzhi ^a   Bai, Xiangjun ^a   Chen, Jige ^a   Chen, Jiajun ^a   Li, Jian ^a   Liu, Peng ^a   Liao, Yiliu ^a  

^a HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

Author keywords

3 polyunsaturated fatty acid; Severe multiple trauma; Toll like receptor 2; Toll like receptor 4

Indexed keywords

OMEGA 3 FATTY ACID; TOLL LIKE RECEPTOR;

ADOLESCENT; ADULT; ARTICLE; FEMALE; HUMAN; MALE; METABOLISM; MIDDLE AGED; MULTIPLE TRAUMA; YOUNG ADULT;

ADOLESCENT; ADULT; FATTY ACIDS, OMEGA-3; FEMALE; HUMANS; MALE; MIDDLE AGED; MULTIPLE TRAUMA; TOLL-LIKE RECEPTORS; YOUNG ADULT;

EID: 80455164789     PISSN: 16720733     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11596-011-0480-6     Document Type: Article

References (13)

1. Novak TE, Babcock TA, Jho DH, et al. NF-kappa B inhibition by omega-3 fatty acids modulates LPS-stimulated macrophage TNF-alpha transcription. Am J Physiol Lung Cell Mol Physiol, 2003,284(1):L84-L89 (Pubitemid 35471261)
2. Hao W, Wong OY, Liu X, et al. ω-3 fatty acids suppress inflammatory cytokine production by macrophages and hepatocytes. J Pediatr Surg, 2010,45(12):2412-2418
3. Zhang W, Long Y, Zhang J, et al. Modulatory effects of EPA and DHA on proliferation and apoptosis of pancreatic cancer cells. J Huazhong Univ Sci Technol (Med Sci), 2007,27(5):547-550
4. Grimm H, Mayer K, Mayser P, et al. Regulatory potential of n-3 fatty acids in immunological and inflammatory processes. Br J Nutr, 2002, 87(1):S59-S67 (Pubitemid 34134104)
5. Heller AR, Rossler S, Litz RJ, et al. Omega-3 fatty acids improve the diagnosis-related clinical outcome. Crit Care Med, 2006,34(4):972-979
6. Calder PC. ω-3 polyunsaturated fatty acids and cytokine production in health and disease. Ann Nutr Metab, 1997,41(4):203-234 (Pubitemid 27472618)
7. Calder PC. ω-3 polyunsaturated fatty acids and inflammation: from molecular biology to the clinic. Lipids, 2003,38(4):343-352 (Pubitemid 36724290)
8. Gabler NK, Spencer JD, Webel DM, et al. n-3 PUFA attenuate lipopolysaccharide-induced down-regulation of toll-like receptor 4 expression in porcine adipose tissue but does not alter the expression of other immune modulators. J Nutr Biochem, 2008,19(1):8-15 (Pubitemid 350213390)
9. Zhao Y, Joshi BS, Barve S, et al. Eieesapentoenoic acid prevents LPS-induced TNF-α expression by preventing NF-κ B activation. J Am Col Nutr, 2004,23(1): 71-78 (Pubitemid 38200837)
10. Li Q, Wang M, Tan L, et al. Docosahexaenoic acid changes lipid composition and interleukin-2 receptor signaling in membrane rafts. J Lipid Res, 2005,48(9): 1904-1913 (Pubitemid 41248487)
11. Chapkin RS, Kim W, Lupton JR, et al. Dietary docosahexaenoic and eicosapentaenoic acid: emerging mediators of inflammation. Prostaglandins Leukot Essent Fatty Acids, 2009,81(2-3):187-191
12. Li WD, Dong YJ, TU YY, et al. Dihydroarteannuin ameliorates lupus symptom of BXSB mice by inhibiting production of TNF-alpha and blocking the signaling pathway NF-kappa B translocation. Int Immunopharmacol, 2006, 6(8):1243-1250
13. Lee JY, Plakidas A, Lee WH, et al. Differential modulation of Toll-like receptors by fatty acids: preferential inhibition by n-3 polyunsaturated fatty acids. J Lipid Res, 2003,44(3):479-486. (Pubitemid 37279695)